Literature DB >> 10636160

Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage.

M O McCarron1, J A Nicoll, J Stewart, J W Ironside, D M Mann, S Love, D I Graham, A Grubb.   

Abstract

In Icelandic pedigrees a cystatin C mutation, glutamine 68 (L68Q), causes autosomal dominant cerebral amyloid angiopathy-related hemorrhage (CAAH). We examined 33 patients with sporadic CAAH for this mutation. None carried L68Q and, including this report, only one of 52 published cases of sporadic CAAH has had the cystatin C mutation. Despite vascular colocalization of cystatin C with amyloid beta-protein, cystatin C L68Q is rare in sporadic CAAH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636160     DOI: 10.1212/wnl.54.1.242

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.

Authors:  Tyler J Perlenfein; Jacob D Mehlhoff; Regina M Murphy
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

2.  Expression, purification, and characterization of human cystatin C monomers and oligomers.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  Protein Expr Purif       Date:  2015-09-25       Impact factor: 1.650

3.  A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

Review 4.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

5.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

Review 6.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.